PIK3CA and cancer: Of note, while these eight PIK3CA NMD participants did not have any PIK3CA SNV detected in baseline ctDNA, they each had a detectable alteration in at least one of the 69 other cancer‐related genes evaluated on the F1L assay, suggesting that ctDNA was present in the blood of these participants.